Medindia

X

Aggressive Breast Cancers may be Sensitive to Drugs Clogging Their Waste Disposal: Research

by Rukmani Krishna on  August 14, 2013 at 12:04 AM Cancer News   - G J E 4
"Triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome reports a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine. This cellular structure acts as the cell's waste disposal, breaking down damaged or unneeded proteins.
 Aggressive Breast Cancers may be Sensitive to Drugs Clogging Their Waste Disposal: Research
Aggressive Breast Cancers may be Sensitive to Drugs Clogging Their Waste Disposal: Research
Advertisement

These cancers, which lack the three major therapeutic markers for breast cancer—the estrogen, progesterone and HER2 receptors—are very aggressive and difficult to treat. They mostly affect younger women and have the worst prognosis of all breast cancers.

Advertisement
By selectively turning genes off throughout the genomes of triple-negative tumor cells in vitro, Lieberman's team found that these cells absolutely require active proteasomes in order to live. When turned off, the cells die.

These data suggest that triple-negative breast cancers may respond to treatment with drugs similar to bortezomib (Velcade®), a proteasome inhibitor that revolutionized the care of patients with the blood cancer multiple myeloma.

Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All